R. C. Green, J. S. Berg, W. W. Grody, S. S. Kalia, B. R. Korf et al., ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing, Genet Med. juill, vol.15, issue.7, pp.565-74, 2013.

P. Pujol, P. Vande-perre, L. Faivre, D. Sanlaville, C. Corsini et al., Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations, Eur J Hum Genet, vol.26, issue.12, pp.1732-1774, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01870352

M. Krahn, N. Lévy, and M. Bartoli, Le séquençage de nouvelle génération ( Next-Generation Sequencing , ou NGS) appliqué au diagnostic de maladies monogéniques hétérogènes: Notions essentielles pour le dialogue entre cliniciens et généticiens. Les Cahiers de Myologie, juin, issue.13, pp.31-34, 2016.

S. Gorokhova, V. Biancalana, N. Lévy, J. Laporte, M. Bartoli et al., Clinical massively parallel sequencing for the diagnosis of myopathies, Rev Neurol (Paris). juill, vol.171, issue.6-7, pp.558-71, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01610014

H. Buermans and J. T. Den-dunnen, Next generation sequencing technology: Advances and applications, Biochim Biophys Acta, vol.1842, issue.10, pp.1932-1973, 2014.

M. Krahn, Collège national des enseignants et praticiens de génétique. Génétique médicale: enseignement thématique, 2016.

Y. L. France-médecine-génomique, Disponible sur, vol.20, pp.16-2025, 2025.

S. Ministère-des, L. De, and . Santé,

D. Sur,

B. Petersen, B. Fredrich, M. P. Hoeppner, D. Ellinghaus, and A. Franke, Opportunities and challenges of whole-genome and -exome sequencing, BMC Genet, vol.14, issue.1, p.14, 2017.

N. T. Strande, E. R. Riggs, A. H. Buchanan, O. Ceyhan-birsoy, M. Distefano et al., Evaluating the Clinical Validity of Gene-Disease Associations: An Evidence-Based Framework Developed by the Clinical Genome Resource, Am J Hum Genet. 1 juin, vol.100, issue.6, pp.895-906, 2017.

G. England-panelapp-;-krahn, M. Cerino, M. Campana-salort, E. Cossée, and M. ,

, Hors série, vol.33, pp.30-33, 2017.

A. Perrin, P. Latour, V. Procaccio, C. Jardel, M. Cérino et al., Towards an harmonization of diagnosis by NGS of neuromuscular diseases -Actions of the Molecular Genetics sub-group of FILNEMUS
URL : https://hal.archives-ouvertes.fr/hal-01938567

, Med Sci (Paris). nov, vol.34, pp.20-22, 2018.

M. Krahn, V. Biancalana, M. Cerino, A. Perrin, L. Michel-calemard et al., A National French consensus on gene lists for the diagnosis of myopathies using nextgeneration sequencing, Eur J Hum Genet. mars, vol.27, issue.3, p.92, 2019.

J. E. Hunter, S. A. Irving, L. G. Biesecker, A. Buchanan, B. Jensen et al., A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation, Genet Med, vol.18, issue.12, pp.1258-68, 2016.

. Acmg-board-of-directors, ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing, Genet Med. janv, vol.17, issue.1, pp.68-77, 2015.

S. S. Kalia, K. Adelman, S. J. Bale, W. K. Chung, C. Eng et al., Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics, Genet Med, vol.19, issue.2, pp.249-55, 2017.

. Acmg-board-of-directors, The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG), Genet Med. 25 avr, 2019.

J. S. Berg, A. Foreman, O. Daniel, J. M. Booker, J. K. Boshe et al., A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing, Genet Med, vol.18, issue.5, pp.467-75, 2016.

E. M. Webber, J. E. Hunter, L. G. Biesecker, A. H. Buchanan, E. V. Clarke et al., Evidence-based assessments of clinical actionability in the context of secondary findings: Updates from ClinGen's Actionability Working Group, Hum Mutat, vol.39, issue.11, pp.1677-85, 2018.

, Épilepsies de l'enfant et de l'adulte

F. Pisani, A. Percesepe, and C. Spagnoli, Genetic diagnosis in neonatal-onset epilepsies: Back to the future, Eur J Paediatr Neurol. mai, vol.22, issue.3, pp.354-361, 2018.

E. Axeen and H. E. Olson, Neonatal epilepsy genetics, Semin Fetal Neonatal Med, vol.23, issue.3, pp.197-203, 2018.

B. Chabro, O. Dulac, J. Mancini, G. Ponsot, and . Neurologie-pédiatrique, Pédiatrie. Lavoisier MSP, 2009.

, ClinGen Actionability Reports

, Myopathies ou Maladies Neuromusculaire

. Afm-téléthon and . Disponible,

, Avancées dans les Glycogénoses Musculaires, Savoir et Comprendre, Avancées de la Recherche

. Afm-téléthon, Biothérapies: des traitements innovants au bénéfice du plus grand nombre, 2019.

. Afm-téléthon, Disponible sur, 2019.

, Avancées dans Dystrophies Musculaires de Duchenne et Becker, Savoir et Comprendre, Avancées de la recherche

. Afm-téléthon, Disponible sur, 2019.

, Sarepta Therapeutics Receives Complete Response Letter from the US Food and Drug Administration for Golodirsen New Drug Application

A. Dans and L. , Amyotrophie Spinale liée à SMN1, Savoir et Comprendre, Avancées de la recherche

. Afm-téléthon, Prise en charge respiratoire et maladies neuromusculaires, Savoir et Comprendre, Repères, 2019.

. Afm-téléthon, Prise en charge orthopédique et maladie neuromusculaire, Savoir et Comprendre, Repères, 2014.

. Afm-téléthon, , 2018.

, ClinGen Pediatric Actionability Workgroup Protocol: Generation of Summary Reports and Semi-Quantitative Metric Scoring

, Banque Nationale de Données des Maladies Rares

F. Miceli, M. V. Soldovieri, N. Joshi, S. Weckhuysen, E. Cooper et al., KCNQ2-Related Disorders

T. Gertler, D. Bearden, A. Bhattacharjee, G. Carvill, M. P. Adam et al., KCNT1-Related Epilepsy, éditeurs. GeneReviews ®

M. F. Hammer, J. L. Wagnon, H. C. Mefford, M. Meisler, M. P. Adam et al., SCN8A-Related Epilepsy with Encephalopathy

M. Cornet, T. T. Sands, and M. R. Cilio, Neonatal epilepsies: Clinical management, Semin Fetal Neonatal Med, vol.23, issue.3, pp.204-216, 2018.

C. M. Molster, K. Lister, S. Metternick-jones, G. Baynam, A. J. Clarke et al., Outcomes of an International Workshop on Preconception Expanded Carrier Screening: Some Considerations for Governments. Front Public Health, vol.5, p.25, 2017.

R. Ong, D. Howting, A. Rea, H. Christian, P. Charman et al., Measuring the impact of genetic knowledge on intentions and attitudes of the community towards expanded preconception carrier screening, J Med Genet. nov, vol.55, issue.11, p.94, 2018.

M. B. Delatycki, N. G. Laing, S. J. Moore, J. Emery, A. D. Archibald et al., Preconception and antenatal carrier screening for genetic conditions: The critical role of general practitioners, Aust J Gen Pract, vol.48, issue.3, pp.106-116, 2019.

, Avancées dans les Myasthénies Congénitales, Savoir et Comprendre, Avancées de la Recherche

N. Leslie, L. Bailey, M. P. Pompe-disease-;-adam, H. H. Ardinger, R. A. Pagon et al., éditeurs. GeneReviews ®

N. D. Leslie, C. A. Valencia, A. W. Strauss, K. Zhang, M. P. Adam et al., Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency, éditeurs. GeneReviews ®

]. Crispr/cas9-[internet and . Disponible,

, Financements et contrat de recherche pour l'étude du déploiement du SHD en diagnostic

D. Sur,

C. Thauvin-robinet, J. Thevenon, S. Nambot, J. Delanne, P. Kuentz et al., Secondary actionable findings identified by exome sequencing: expected impact on the organisation of care from the study of 700 consecutive tests, Eur J Hum Genet. août, vol.27, issue.8, pp.1197-214, 2019.

F. Houdayer, O. Putois, M. L. Babonneau, H. Chaumet, L. Joly et al., Secondary findings from next generation sequencing: Psychological and ethical issues. Family and patient perspectives, Eur J Med Genet. 29 juin, 2019.

. Avis, Comité Consultatif Nationnal d'Ethique. Données massives et santé : Etat des lieux, prospective et nouvelles questions éthiques

J. Delanne, S. Nambot, A. Chassagne, O. Putois, A. Pelissier et al., Secondary findings from whole-exome/genome sequencing evaluating stakeholder perspectives. A review of the literature, Eur J Med Genet. juin, vol.62, issue.6, p.103529, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02058797